Caribou Biosciences (CRBU) Short-term Investments (2021 - 2026)

Caribou Biosciences (CRBU) has 6 years of Short-term Investments data on file, last reported at $105.6 million in Q1 2026.

• Short-term Investments for Q1 2026 came in at $105.6 million, down 41.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $105.6 million (down 41.04% YoY), and the FY2025 annual result was $127.0 million, down 34.29% from the prior year.
• Short-term Investments slipped to $105.6 million in Q1 2026 per CRBU's latest filing, from $127.0 million in the prior quarter.
• Over five years, Short-term Investments peaked at $277.7 million in Q4 2023 and troughed at $105.6 million in Q1 2026.
• A 5-year average of $192.9 million and a median of $193.2 million in 2024 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2023 and 2026: Short-term Investments soared 46.66% in 2023, then tumbled 41.04% in 2026.
• A 5-year view of Short-term Investments shows it stood at $189.3 million in 2022, then surged by 46.66% to $277.7 million in 2023, then tumbled by 30.4% to $193.2 million in 2024, then tumbled by 34.29% to $127.0 million in 2025, then retreated by 16.86% to $105.6 million in 2026.
• Business Quant data shows CRBU's Short-term Investments at $105.6 million in Q1 2026, $127.0 million in Q4 2025, and $136.1 million in Q3 2025.